Search results summary
From Health Canada
Search criteria
- Status: Select all
- AIG: 0152713001
Search results
Status | DIN | Company | Product | Class | PM See footnote1 | Schedule | # See footnote2 | A.I. name See footnote3 | Strength |
---|---|---|---|---|---|---|---|---|---|
Marketed | 02350092 | HOFFMANN-LA ROCHE LIMITED | ACTEMRA | Human | Yes | Schedule D | 1 | TOCILIZUMAB | 80 MG / 4 ML |
Marketed | 02350092 | HOFFMANN-LA ROCHE LIMITED | ACTEMRA | Human | Yes | Prescription | 1 | TOCILIZUMAB | 80 MG / 4 ML |
Marketed | 02350106 | HOFFMANN-LA ROCHE LIMITED | ACTEMRA | Human | Yes | Prescription | 1 | TOCILIZUMAB | 200 MG / 10 ML |
Marketed | 02350106 | HOFFMANN-LA ROCHE LIMITED | ACTEMRA | Human | Yes | Schedule D | 1 | TOCILIZUMAB | 200 MG / 10 ML |
Marketed | 02350114 | HOFFMANN-LA ROCHE LIMITED | ACTEMRA | Human | Yes | Schedule D | 1 | TOCILIZUMAB | 400 MG / 20 ML |
Marketed | 02350114 | HOFFMANN-LA ROCHE LIMITED | ACTEMRA | Human | Yes | Prescription | 1 | TOCILIZUMAB | 400 MG / 20 ML |
Approved | 02552450 | FRESENIUS KABI CANADA LTD | TYENNE | Human | Yes | Prescription | 1 | TOCILIZUMAB | 80 MG / 4 ML |
Approved | 02552450 | FRESENIUS KABI CANADA LTD | TYENNE | Human | Yes | Schedule D | 1 | TOCILIZUMAB | 80 MG / 4 ML |
Approved | 02552469 | FRESENIUS KABI CANADA LTD | TYENNE | Human | Yes | Schedule D | 1 | TOCILIZUMAB | 200 MG / 10 ML |
Approved | 02552469 | FRESENIUS KABI CANADA LTD | TYENNE | Human | Yes | Prescription | 1 | TOCILIZUMAB | 200 MG / 10 ML |
Approved | 02552477 | FRESENIUS KABI CANADA LTD | TYENNE | Human | Yes | Schedule D | 1 | TOCILIZUMAB | 400 MG / 20 ML |
Approved | 02552477 | FRESENIUS KABI CANADA LTD | TYENNE | Human | Yes | Prescription | 1 | TOCILIZUMAB | 400 MG / 20 ML |
Application information
Related information
Contact us
Version 4.0.3